Abstract:Porcine reproductive and respiratory syndrome virus (PRRSV), one of the most economically significant pathogens worldwide, has caused numerous outbreaks during the past 30 years. PRRSV infection causes reproductive failure in sows and respiratory disease in growing and finishing pigs, leading to huge economic losses for the swine industry. This impact has become even more significant with the recent emergence of highly pathogenic PRRSV strains from China, further exacerbating global food security. Since new PRRSV variants are constantly emerging from outbreaks, current strategies for controlling PRRSV have been largely inadequate, even though our understanding of PRRSV virology, evolution and host immune response has been rapidly expanding. Meanwhile, practical experience has revealed numerous safety and efficacy concerns for currently licensed vaccines, such as shedding of modified live virus (MLV), reversion to virulence, recombination between field strains and MLV and failure to elicit protective immunity against heterogeneous virus. Therefore, an effective vaccine against PRRSV infection is urgently needed. Here, we systematically review recent advances in PRRSV vaccine development. Antigenic variations resulting from PRRSV evolution, identification of neutralizing epitopes for heterogeneous isolates, broad neutralizing antibodies against PRRSV, chimeric virus generated by reverse genetics, and novel PRRSV strains with interferon-inducing phenotype will be discussed in detail. Moreover, techniques that could potentially transform current MLV vaccines into a superior vaccine will receive special emphasis, as will new insights for future PRRSV vaccine development. Ultimately, improved PRRSV vaccines may overcome the disadvantages of current vaccines and minimize the PRRS impact to the swine industry.

THE RESEARCH PROGRESS ON EXPRESSION OF FOREIGN GENE BASED ON THE PRRSV INFECTIOUS CLONE

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus.

Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines

Research Progress on Diagnostic Method and Vaccine of Porcine Reproductive and Respiratory Syndrome

Molecular Characterization of Three Porcine Reproductive and Respiratory Syndrome Virus Isolates and Their Susceptibility to Antiviral Drugs

Improved Vaccine against PRRSV: Current Progress and Future Perspective.

The Advance in Molecular Biology of Porcine Reproductive and Respiratory Syndrome Virus

The Research Advance of Porcine Reproductive and Respiratory Syndrome Virus

Research Progress on the Molecular Mechanism of Immune Escape of Porcine Reproductive and Respiratory Syndrome Virus

The Molecular Characteristic Analysis of PRRSV GSWW/2015 Strain and Its Pathogenicity to Pigs

Advances in Pathogenesis and Resistance Breeding of Porcine Reproductive and Respiratory Syndrome Virus

Development and biological characterization of an infectious cDNA clone of NADC34-like PRRSV

Progress in PRRSV Infection and Adaptive Immune Response Mechanisms

Research Advances in Non-Structural Protein 2 of Porcine Reproductive and Respiratory Syn-Drome Virus

[Advances in Understanding of the Infection/Replication Mechanisms and Virulence Determinants of the Porcine Reproductive and Respiratory Syndrome Virus].

Research Progress on Molecular Biology of Pocine Reproduction and Respiratary Syndrome Virus

Construction of Recombinant Canine Adenovirus Type-1 Expressing the GP5 of Porcine Reproductive and Respiratory Syndrome Virus(prrsv) and Its Immunological Property in Pigs

Research Progress on the Protein of PRRSV

Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and their potential as vaccine vectors

Research Progress on the detection methods of porcine reproductive and respiratory syndrome virus